Artificial Organs And Bionics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 130 Pages I Mordor Intelligence
Artificial Organs And Bionics Market Analysis
The artificial organs and bionics market is worth USD 31.99 billion in 2025 and is forecast to reach USD 45.29 billion in 2030, advancing at a 7.20% CAGR. Size expansion is being shaped by converging breakthroughs in biomaterials, miniaturized electronics, and 3-D bioprinting, all of which compress development timelines and lift clinical adoption of cardiovascular, renal, and neuro-prosthetic devices. Stretched transplant waiting lists and fast-track regulatory programs are spurring investment in total artificial hearts, wearable artificial kidneys, and next-generation brain-computer interfaces. Defense-funded limb-restoration programs have unlocked neural-interface know-how that is flowing into civilian solutions, while insurers' gradual acceptance of home-based bionic therapies broadens the treated population. Supply-chain fragilities surrounding rare-earth sensors and high-end chips remain a watchpoint, yet growing regional manufacturing footprints in Asia-Pacific are easing part of that exposure.
Global Artificial Organs And Bionics Market Trends and Insights
Rising Incidence of Chronic Organ Failure & Disabilities
Degenerative ailments are swelling the addressable pool for cardiac assist devices, renal replacements, and neuro-prosthetics. Cardiovascular disease affects 49 million people in the EU, energising demand for mechanical circulatory support systems. Japan's insulin-producing iPS-cell trials underscore momentum behind a bioartificial pancreas for 139,000 local type 1 diabetes patients. Ageing populations translate into rising stroke-related motor deficits, setting the stage for brain-computer interfaces that restore communication and mobility. The U.S. Department of Veterans Affairs is backing 25 prosthetics-oriented projects in FY 2025, signalling continuing long-term demand.
Scarcity of Donor Organs
More than 103,000 Americans wait for transplants; in Japan, fewer than 3% of organ-failure patients receive brain-dead donations, reinforcing demand for alternatives. FDA-sanctioned pig-organ trials in 2025 are emblematic of the shift toward xenotransplantation. Bridge-to-transplant devices such as the Carmat Aeson artificial heart have kept 30 European patients alive for an average of 156 days. China's 45-gram pediatric artificial heart answers an acute need in children's cardiac support.
High Procedure & Device Cost
Robotic knees can reach USD 51,000, and private insurers often cap prosthetic reimbursement, leaving patients exposed to six-figure out-of-pocket bills. Colorado's Medicare-parity law illustrates patchy progress on coverage mandates. Total artificial heart therapy, including surgery and follow-up, can surpass USD 500,000 per person, restricting uptake to high-resource centers. The cost barrier is sharper in emerging markets, where reimbursement rates lag device prices.
Other drivers and restraints analyzed in the detailed report include:
Rapid Biomaterial, Micro-Electronics & 3-D Bio-Printing Advances / Defence-Funded Limb-Restoration Programmes (Post-2024) / Biocompatibility Issues & Device Malfunctions /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Artificial organs commanded 70.26% of the artificial organs and bionics market in 2024 as transplant shortages sustained demand for ventricular assist devices and emerging bioartificial kidneys. Bionics is tracking an 8.25% CAGR to 2030, aided by miniaturised brain-computer interfaces that now facilitate speech and fine-motor control. The artificial organs and bionics market size for heart devices alone is projected to expand at 7.8% CAGR, supported by FDA breakthrough tags for titanium total artificial hearts.
Clinical momentum is evident in renal assist systems where Roivios obtained breakthrough designation and is preparing U.S. pivotal trials. Bio-printed liver constructs and gene-edited pig livers are progressing through early-phase studies, signalling pipeline depth. Neuro-bionics growth is amplified by AI-driven control algorithms that adapt in milliseconds to user intent. Collectively, these innovations anchor long-term revenue visibility across the artificial organs and bionics market.
The Artificial Organs and Bionics Market Report is Segmented by Device Type (Artificial Organs [Artificial Heart, Artificial Kidney, and More] and Bionics [Vision Bionics, Ear Bionics, and More]), Technology (Implantable Devices and Wearable Devices), End User (Hospitals & Surgical Centres, Home-Care and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America retained 38.82% share of the artificial organs and bionics market in 2024 on the back of an established FDA fast-track framework and robust venture funding. Investors topped USD 2 billion in disclosed U.S. deals during 2024, half of which went to cardiac and neuro-prosthesis start-ups. The region's mature reimbursement infrastructure continues to favour early adoption, yet price sensitivity is rising as payers scrutinise cost-effectiveness.
Asia-Pacific is the fastest-growing region with a 10.62% CAGR, catalysed by Japan's universal artificial blood that maintains two-year shelf life across all blood types. China's triple-integrated brain-spine interface enabled paraplegic patients to regain over-ground walking within weeks, positioning domestic players at the cutting edge of neuro-prosthetics. Pediatric device innovation is also notable: a 45-gram artificial heart designed for small children filled a vital niche, reinforcing regional clinical leadership.
Europe sustains a technology leadership role through companies such as Carmat, whose Aeson artificial heart received CE marking as a bridge-to-transplant therapy. German transplant centres reported the first fully implantable artificial-heart discharge to home care, broadening real-world validation. Parallel initiatives in organ-preservation perfusion systems further tighten the supply-demand gap for donor organs, keeping Europe firmly inside the high-innovation quadrant of the artificial organs and bionics market.
List of Companies Covered in this Report:
Abbott Laboratories / Abiomed / Asahi Kasei Medical / Baxter / Berlin Heart / Boston Scientific / Cochlear / CYBERDYNE / Ekso Bionics / Edward Lifesciences / Getinge / MED-EL / Medtronic / Ossur / Ottobock / Second Sight Medical Products / SynCardia Systems / Sonova / Zimmer Biomet /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence Of Chronic Organ Failure & Disabilities
4.2.2 Scarcity Of Donor Organs
4.2.3 Rapid Biomaterial, Micro-Electronics & 3-D Bio-Printing Advances
4.2.4 Defence-Funded Limb-Restoration Programmes (Post-2024)
4.2.5 Fast-Track Regulatory Pathways (FDA BTD, EU MDR Art 117)
4.3 Market Restraints
4.3.1 High Procedure & Device Cost
4.3.2 Biocompatibility Issues & Device Malfunctions
4.3.3 Supply-Chain Fragility Of Rare-Earth Sensors & Chips
4.4 Technological Outlook
4.5 Porter's Five Forces
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitutes
4.5.5 Intensity of Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Device Type
5.1.1 Artificial Organs
5.1.1.1 Artificial Heart
5.1.1.2 Artificial Kidney
5.1.1.3 Artificial Lungs
5.1.1.4 Artificial Liver
5.1.1.5 Artificial Pancreas
5.1.1.6 Others
5.1.2 Bionics
5.1.2.1 Vision Bionics
5.1.2.2 Ear Bionics
5.1.2.3 Orthopedic Bionics
5.1.2.4 Cardiac Bionics
5.1.2.5 Neural Bionics
5.2 By Technology
5.2.1 Implantable Devices
5.2.2 Wearable / Extracorporeal Devices
5.3 By End User
5.3.1 Hospitals & Surgical Centres
5.3.2 Specialty & Rehabilitation Clinics
5.3.3 Home-care & Ambulatory Settings
5.3.4 Military & Veterans Care Systems
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 South Korea
5.4.3.5 Australia
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 Abiomed
6.3.3 Asahi Kasei Medical
6.3.4 Baxter International
6.3.5 Berlin Heart
6.3.6 Boston Scientific Corporation
6.3.7 Cochlear Ltd
6.3.8 CYBERDYNE
6.3.9 Ekso Bionics
6.3.10 Edwards Lifesciences
6.3.11 Getinge AB
6.3.12 MED-EL
6.3.13 Medtronic plc
6.3.14 Ossur
6.3.15 Ottobock
6.3.16 Second Sight Medical
6.3.17 SynCardia Systems
6.3.18 Sonova
6.3.19 Zimmer Biomet
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.